Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

<div><p>With the advent of the genetic era in Parkinson’s disease (PD) research in 1997, α-synuclein was identified as an important player in a complex neurodegenerative disease that affects >10 million people worldwide. PD has been estimated to have an economic impact of $51.9 billio...

Full description

Saved in:
Bibliographic Details
Main Author: Luis M. A. Oliveira (18459000) (author)
Other Authors: Thomas Gasser (33499) (author), Robert Edwards (1230) (author), Markus Zweckstetter (133481) (author), Ronald Melki (102380) (author), Leonidas Stefanis (264252) (author), Hilal A. Lashuel (261037) (author), David Sulzer (86849) (author), Kostas Vekrellis (214282) (author), Glenda M. Halliday (11232982) (author), Julianna J. Tomlinson (15257035) (author), Michael Schlossmacher (4377472) (author), Poul Henning Jensen (7490708) (author), Julia Schulze-Hentrich (18459003) (author), Olaf Riess (110686) (author), Warren D. Hirst (238891) (author), Omar El-Agnaf (2134222) (author), Brit Mollenhauer (482499) (author), Peter Lansbury (5154518) (author), Tiago F. Outeiro (191379) (author)
Published: 2021
Subjects:
Biomedical and clinical sciences
Neurosciences
Parkinson’s disease (PD)
α-synuclein
Genetic era
Neurodegenerative disease
Epidemiology
Economic impact
Research
Functions
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items